Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies

被引：120

作者：

Badreldin, Hisham A. ^{[1
,2
,3
]}

Atallah, Bassam ^{[4
,5
]}

机构：

[1] King Saud bin Abdulaziz Univ Hlth Sci, Coll Pharm, Dept Pharm Practice, POB 3660, Riyadh 11481, Saudi Arabia

[2] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia

[3] King Abdul Aziz Med City, Dept Pharmaceut Care Serv, Riyadh, Saudi Arabia

[4] Cleveland Clin Abu Dhabi, Dept Pharm Serv, Abu Dhabi, U Arab Emirates

[5] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA

来源：

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY | 2021年 / 17卷 / 01期

关键词：

Coronavirus; COVID-19; Pandemic; Drug shortage; Pharmacist; Policymaker; MANAGEMENT;

D O I：

10.1016/j.sapharm.2020.05.017

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policy makers in alleviating this emerging problem.

引用

页码：1946 / 1949

页数：4

共 24 条

[1] Drug shortages in Saudi Arabia: Root causes and recommendations [J].